Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00544076 · ClinicalTrials.gov registry record · Phase 3
ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer
A Phase 3 study, sponsored by City of Hope Medical Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 110
- Enrollment target
NCT00544076: Clinical Trial Phase 3 study, sponsored by City of Hope Medical Center.
NCT00544076 is a Phase 3 study that was terminated before completion, run by City of Hope Medical Center. The registered enrollment target is 110 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00544076, a Phase 3 study, was terminated before completion, sponsored by City of Hope Medical Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 110 participants
- Enrollment target
Study Summary
RATIONALE: Sildenafil citrate and alprostadil may help patients who have undergone prostatectomy for prostate cancer to recover from erectile dysfunction. PURPOSE: This randomized clinical trial is studying giving sildenafil together with alprostadil in treating patients undergoing nerve-sparing robotic-assisted radical prostatectomy for nonmetastatic prostate cancer.
Primary Outcome
Potency rates (ability to obtain an erection sufficient for penetration) without assistance in those patients receiving maintenance Viagra compared to non-pharmacology controls was compared at 12 months from start of treatment using the fisher's exact test
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- DRUG sildenafil citrate
- DRUG alprostadil
- PROCEDURE robotic-assisted laparoscopic surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2006-01 |
| Est. Completion | 2012-04 |
| Phase | Phase 3 |
Why NCT00544076 stopped before completion
NCT00544076 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 5 interventions - of which questionnaire administration is the first listed.
NCT00544076 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00544076 about?
NCT00544076 is a clinical study titled "ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer". RATIONALE: Sildenafil citrate and alprostadil may help patients who have undergone prostatectomy for prostate cancer to recover from erectile dysfunction. PURPOSE: This randomized clinical trial is studying giving sildenafil together with alprostadil in treating patients undergoing nerve-sparing ro...
What is the current status of trial NCT00544076?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 110 participants. The study started on 2006-01. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00544076?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), sildenafil citrate (DRUG), alprostadil (DRUG), robotic-assisted laparoscopic surgery (PROCEDURE).
Who is sponsoring clinical trial NCT00544076?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00544076's enrollment target sits among peer trials
110 1657th of 2000 higher than 337 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia